Valsts: Īrija
Valoda: angļu
Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)
CALCIUM GLUCONATE, MAGNESIUM HYPOPHOSPHITE, GLUCOSE MONOHYDRATE, BORIC ACID
Chem-Pharm
QA12
CALCIUM GLUCONATE, MAGNESIUM HYPOPHOSPHITE, GLUCOSE MONOHYDRATE, BORIC ACID
%w/v
Solution for Injection
LM-Licensed Merchant
Ovine
MINERAL SUPPLEMENTS
Vitamins & Minerals
Authorised
2001-10-01
IRISH MEDICINES BOARD ACT 1995 EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (NO. 2) REGULATIONS 2007 (S.I. NO. 786 OF 2007) VPA: 10823/014/001 Case No: 7002643 The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies (No. 2) Regulations (S.I. No. 786 of 2007) hereby grants to: CHEM-PHARM BALLYVAUGHAN, CO. CLARE, IRELAND an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the Veterinary Medicinal Product: CALCIPHARM PMD SOLUTION FOR INJECTION The particulars of which are set out in Part 1 and Part 2 of the said Schedule. The authorisation is also subject to any special conditions as may be specified in the said Schedule. The authorisation, unless previously revoked, shall continue in force from 01/10/2006. Signed on behalf of the Irish Medicines Board ________________ A person authorised in that behalf by the said Board. (NOTE: From this date of effect, this authorisation replaces any previous authorisation in respect of this product which is now null and void.) IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 24/03/2009_ _CRN 7002643_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Calcipharm PMD Solution for Injection. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. A clear pale yellow sterile aqueous solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Sheep 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Calcipharm PMD is indicated in the treatment of hypocalcaemia complicated by a deficiency of Magnesium with accompa Izlasiet visu dokumentu